Quick Answer
Sunshine Biopharma Inc. reported Total Assets of $30.56 million for the year ending 2024.
- Sunshine Biopharma Inc. showed an increase of +11.8% in Total Assets from 2023 to 2024.
- This data is from Sunshine Biopharma Inc.'s annual report (Form 10-K), filed with the SEC on April 1, 2025.
- XBRL data for this metric is available from 2010 to 2024 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2011: $159.3 thousand | Q2 2011: $142.5 thousand | Q3 2011: $224.2 thousand | Q1 2012: $84.2 thousand | Q2 2012: $109.0 thousand | Q3 2012: $268.0 thousand | Q1 2013: $259.0 thousand | Q2 2013: $160.8 thousand | Q3 2013: $71.6 thousand | Q1 2014: $71.8 thousand | Q2 2014: $44.1 thousand | Q3 2014: $180.3 thousand | Q1 2015: $148.7 thousand | Q2 2015: $170.7 thousand | Q3 2015: $136.6 thousand | Q1 2016: $830.6 thousand | Q2 2016: $742.4 thousand | Q3 2016: $599.3 thousand | Q1 2017: $23.4 thousand | Q2 2017: $164.3 thousand | Q3 2017: $256.0 thousand | Q1 2018: $1.00 million | Q2 2018: $1.17 million | Q3 2018: $1.10 million | Q1 2019: $1.25 million | Q2 2019: $109.4 thousand | Q3 2019: $146.3 thousand | Q1 2020: $63.7 thousand | Q2 2020: $138.5 thousand | Q3 2020: $550.5 thousand | Q1 2021: $1.86 million | Q2 2021: $1.82 million | Q3 2021: $2.50 million | Q1 2022: $13.41 million | Q2 2022: $41.99 million | Q3 2022: $40.86 million | Q1 2023: $26.99 million | Q2 2023: $28.41 million | Q3 2023: $27.65 million | Q1 2024: $31.90 million | Q2 2024: $29.30 million | Q3 2024: $30.06 million | Q4 2024: $30.56 million | Q1 2025: $29.19 million | Q2 2025: $31.97 million | Q3 2025: $31.49 million.
- Over the full 15 years of available data (2010 to 2024), Sunshine Biopharma Inc.'s Total Assets has grown by 14,619.1%.
- Historical annual values: Fiscal year 2024: $30.56 million | Fiscal year 2023: $27.35 million | Fiscal year 2022: $29.24 million | Fiscal year 2021: $2.20 million | Fiscal year 2020: $1.05 million | Fiscal year 2019: $98.1 thousand | Fiscal year 2018: $1.15 million | Fiscal year 2017: $257.5 thousand | Fiscal year 2016: $64.4 thousand | Fiscal year 2015: $673.3 thousand | Fiscal year 2014: $143.4 thousand | Fiscal year 2013: $31.2 thousand | Fiscal year 2012: $134.8 thousand | Fiscal year 2011: $106.4 thousand | Fiscal year 2010: $207.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: